Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• GNAO1 mutations cause severe early-infancy encephalopathy with developmental delay and seizures.
• The precise function of G protein subunit alpha O1 (Gαo) in brain development is not fully understood.
• Current therapeutic strategies for GNAO1-associated encephalopathy are limited.

Purpose of the Study:

• To investigate the role of Gαo in the developing brain.
• To identify molecular pathways regulated by Gαo.
• To explore potential therapeutic targets for GNAO1-associated encephalopathy.

Main Methods:

• siRNA-mediated depletion of Gnao1 in Neuro2a cells to analyze gene expression.
• Differentiation of induced pluripotent stem cells (iPSCs) from a patient with a GNAO1 variant (p.G203R) into neurons and cortical organoids.
• Assessment of neurite outgrowth, growth cone formation, neuro-spherical assembly, and phospho-MLC2 polarization.
• Treatment with Rho kinase inhibitor Y27632.

Main Results:

• Gnao1 depletion altered transcripts in Rho GTPase signaling pathways and impaired neurite outgrowth.
• Patient-derived neurons showed disrupted growth cone formation.
• Cortical organoids exhibited defects in neuro-spherical assembly and cell polarization.
• Treatment with Y27632 rescued these morphological abnormalities.

Conclusions:

• Gαo is crucial for the self-organization of the developing brain, regulating the Rho-associated pathway.
• The Rho GTPase pathway represents a potential therapeutic target for GNAO1-associated encephalopathy.
• Understanding Gαo's role provides insights into neurodevelopmental disorders.